Vote Scores
Filings read through

Sichuan Kelun Pharmaceutical Co., Ltd.: how funds voted at the meeting of 15 May 2024

Meeting
Season
year to 30 June 2024
Filers reporting
40
Ballot items
9

40 filers on Form N-PX reported votes at the Sichuan Kelun Pharmaceutical Co., Ltd. meeting of 15 May 2024. The records fall into 9 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Sichuan Kelun Pharmaceutical Co., Ltd. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    9 nominees. 92.3% of the reported votes are for. 20 filers withheld from or voted against at least one nominee.

    604 vote records from 40 filers. 0 of the 40 filers that marked the item voted against management.

    • Positions of 24 fund families
    • For 24
  2. Item 2: Audit-related items (auditor ratification)

    82 vote records from 40 filers. 1 of the 40 filers that marked the item voted against management.

    • Positions of 24 fund families
    • For 23
    • Abstain or withhold 1
    • Against management 1
  3. Item 3: EXTRAORDINARY TRANSACTIONS: management items

    The company's items in this category are shown together, because filers word and number them differently.

    61 vote records from 35 filers. 30 of the 35 filers that marked the item voted against management.

    • Positions of 20 fund families
    • For 3
    • Against 17
    • Against management 17
  4. Item 4: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    340 vote records from 40 filers. 0 of the 40 filers that marked the item voted against management.

    • Positions of 24 fund families
    • For 24
  5. Item 5: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    132 vote records from 40 filers. 0 of the 40 filers that marked the item voted against management.

    • Positions of 24 fund families
    • For 24
  6. Item 6: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    293 vote records from 40 filers. 0 of the 40 filers that marked the item voted against management.

    • Positions of 24 fund families
    • For 24
  7. Item 7: OTHER: management items

    The company's items in this category are shown together, because filers word and number them differently.

    56 vote records from 6 filers. 0 of the 6 filers that marked the item voted against management.

    • Positions of 3 fund families
    • For 3
  8. Item 8: Shareholder proposal: AUDIT-RELATED (A)

    54 vote records from 29 filers. 0 of the 29 filers that marked the item voted against management.

    • Positions of 17 fund families
    • For 17
  9. Item 9: Shareholder proposal: AUDIT-RELATED (B)

    54 vote records from 29 filers. 0 of the 29 filers that marked the item voted against management.

    • Positions of 17 fund families
    • For 17

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Sichuan Kelun Pharmaceutical Co., Ltd., meeting of 15 May 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Auditor8. Proposal9. Proposal
AllianceBernsteinAbstain, against managementForFor
BlackRock and iSharesForForFor
BNY MellonForForFor
Charles SchwabForNo reportNo report
DimensionalForForFor
FidelityForForFor
Franklin TempletonForForFor
Goldman SachsForForFor
J.P. MorganForNo reportNo report
Jackson National fundsForNo reportNo report
John Hancock and ManulifeForNo reportNo report
Lincoln FinancialForForFor
Morgan Stanley, Eaton Vance and CalvertForForFor
NationwideForForFor
Northern Trust and FlexSharesForForFor
Nuveen and TIAAForForFor
Pacific Life fundsForForFor
PGIM and PrudentialForNo reportNo report
Russell InvestmentsForNo reportNo report
SEIForNo reportNo report
State Street and SPDRForForFor
VanguardForForFor
VoyaForForFor
WisdomTreeForForFor

Questions

How many filers reported votes at the Sichuan Kelun Pharmaceutical Co., Ltd. meeting?
40 Form N-PX filers reported votes at the meeting of 15 May 2024. The filings show 2 separate proposals from security holders.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Sichuan Kelun Pharmaceutical Co., Ltd. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Sichuan Kelun Pharmaceutical Co., Ltd. with a meeting date within three days of 15 May 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .